Axsome Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they exploit animals for product testing.
Some news items:
Axsome Therapeutics Announces Publication Of Research Showing AXS-02 Inhibits Pain In Animal Model Of Complex Regional Pain Syndrome. The company examined the effect of oral zoledronate on pain behavior in the rat tibia fracture model of CRPS – Globe Newswire.
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of central nervous system disorders.